在IgG4相关的胰腺胆道疾病中,辅助内镜胆道排水是否能改善除单独使用葡萄糖皮质类药物之外的结果?
Zinan Zhang1, Yanbin Wei1, Jiafei Peng1
1State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
BMC gastroenterology
|November 7, 2025
概括
葡萄糖皮质体 (GCs) 加上内镜胆道排水 (EBD) 在治疗与单独使用GCs相比,与免疫球蛋白G4 (IgG4) 相关的胰腺胆道疾病没有显著差异. 然而,EBD在缓解胆道阻塞方面提供了好处.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 与免疫球蛋白G4 (IgG4) 相关的胰腺胆道疾病呈现出阻塞性黄,这给治疗带来了挑战.
- 葡萄糖皮质类药物 (GCs) 是标准疗法,但具有高复发率和可变的耐受性.
- 除了GC外,内镜胆道排水 (EBD) 的作用也在争论中,对比研究有限.
研究的目的:
- 为了比较组合治疗 (GCs + EBD) 与IgG4相关的胰腺胆道疾病的GCs单一治疗的疗效和安全性.
- 为了确定与IgG4相关的胰腺胆道疾病治疗的患者中复发的风险因素.
主要方法:
- 一项对55名IgG4相关胰腺胆道疾病患者的回顾性研究.
- 患者被分为GC和GC + EBD组.
- 收集治疗后一年的临床数据,以评估疗效,并发症和复发;物流回归确定了风险因素.
主要成果:
- 两组都显示出总胆红素 (TBIL) 和IgG4水平以及普通胆道直径的显著降低.
- GCs + EBD组在12个月后的TBIL改善更大;其他疗效措施相似.
- 在一年内,在组之间没有观察到复发率的显著差异.
- 基线IgG4水平升高被确定为复发的独立风险因素.
结论:
- 组合疗法 (GCs + EBD) 与单独治疗的GCs相比,没有显著改善免疫学缓解,并发症率或复发率.
- 透视胆道排水 (EBD) 在缓解胆道阻塞方面表现出好处.
- 基线IgG4水平升高预测IgG4相关的胰腺胆道疾病的复发.
相关概念视频
Endoscopic Procedures V: ERCP
2.6K
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
2.6K
Acute Pancreatitis II: Clinical Manifestations and Management
713
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
713
Chronic Pancreatitis II: Collaborative Care
303
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
303
Inflammatory Bowel Disease V: Surgical Management
430
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
430
Chronic Bowel Disorders: Introduction
736
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
736
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
420
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
420

